Physician lesson

Cancer cachexia: assessment and management

Weight loss and loss of appetite in advanced cancer, based on the ASCO guideline

Updated: 28 October 20261 min read1 reference

Key points

  • Assess every patient with advanced cancer and weight loss or poor appetite, and refer them for nutritional counselling [1].
  • No drug is routinely recommended for cachexia; a progestin or a short course of corticosteroid only to improve appetite, weighing the side effects [1].
  • Tube or parenteral feeding is not routinely recommended for cachexia in advanced cancer [1].

Assessment

Weight and its trend, appetite, treatable causes (pain, nausea, constipation, mouth sores, depression, swallowing problems, obstruction) and the expectations of the patient and family [1].

Treatment

Summary of the ASCO guideline [1]
InterventionRecommendation
Nutritional counsellingSuggested; the aim is enjoyment of food and less worry
Oral supplementsAccording to individual need
Progestin (megestrol)For appetite; risk of thrombosis and adrenal insufficiency
Corticosteroid (dexamethasone)Short term (a few weeks) for appetite and energy
Tube or parenteral feedingNot routinely, except in selected patients (for example obstruction with a long prognosis)

References

1 reference
Show all references, 1 with a study cardClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Management of Cancer Cachexia: ASCO GuidelineRoeland EJ, Bohlke K, Baracos VE, et al · J Clin Oncol · 2020;38:2438-2453
    Study cardDOIPubMed Back to text: 1 2 3 4 5

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.